 |
epoprostenol |
|---|---|
| Trade Name | Flolan |
| Orphan Indication | Secondary pulmonary hypertension |
| USA Market Approval | USA |
| USA Designation Date | 1999-03-22 00:00:00 |
| Sponsor | GlaxoSmithKline;2301 Renaissance Blvd, P. O. Box 61540;King of Prussia, Pennsylvania, 19406 |
| |
epoprostenol |
|---|---|
| Trade Name | Flolan |
| Orphan Indication | Secondary pulmonary hypertension |
| USA Market Approval | USA |
| USA Designation Date | 1999-03-22 00:00:00 |
| Sponsor | GlaxoSmithKline;2301 Renaissance Blvd, P. O. Box 61540;King of Prussia, Pennsylvania, 19406 |